Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. 2003

C Rochon, and I Tauveron, and C Dejax, and P Benoit, and P Capitan, and A Fabricio, and C Berry, and C Champredon, and P Thieblot, and J Grizard
Unité de Nutrition et Métabolisme Protéique, INRA Centre de Clermont-Ferrand, 63122 Saint-Genès Champanelle, France.

We have examined insulin action on glucose metabolism in six hypothyroid patients before and after regular thyroid hormone treatment, and in six healthy volunteers before and after transient induction of moderate hyperthyroidism. Insulin was infused under euglycaemic and eukalaemic clamps. An appropriate amino acid infusion was used to blunt insulin-induced decreases in amino acid levels. Glucose kinetics were assessed using a primed continuous infusion of [6,6-(2)H(2)]glucose. The results showed that basal plasma insulin and glucose levels (i.e. before infusion) were similar in each case. Despite similar insulin infusion rates, the plateau value of insulin was lower after thyroid treatment in both hypothyroid patients and healthy volunteers. The rate of exogenous glucose needed to maintain plasma glucose at a steady-state level was increased by thyroid hormone in hypothyroid patients (P <0.05), but not in healthy volunteers. Thyroid treatment resulted in a significant increase in basal glucose disposal in both groups (P <0.05). Insulin, in conjunction with glucose and amino acids, significantly stimulated glucose disposal (P <0.05) under all conditions. The incremental increase in glucose disposal after infusion tended to be higher following thyroid hormone treatment, but this was not statistically significant. However, the ratio of the incremental increase in glucose disposal to the increase in plasma insulin was significantly improved after thyroid hormone treatment in hypothyroid patients (P <0.05). It was also increased in healthy volunteers, but not significantly. We conclude that thyroid hormones improve the ability of insulin to stimulate glucose disposal related to insulinaemia. This phenomenon may be highly sensitive, because it was only apparent at low thyroid hormone levels.

UI MeSH Term Description Entries
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose

Related Publications

C Rochon, and I Tauveron, and C Dejax, and P Benoit, and P Capitan, and A Fabricio, and C Berry, and C Champredon, and P Thieblot, and J Grizard
September 1990, Clinical science (London, England : 1979),
C Rochon, and I Tauveron, and C Dejax, and P Benoit, and P Capitan, and A Fabricio, and C Berry, and C Champredon, and P Thieblot, and J Grizard
July 1975, Metabolism: clinical and experimental,
C Rochon, and I Tauveron, and C Dejax, and P Benoit, and P Capitan, and A Fabricio, and C Berry, and C Champredon, and P Thieblot, and J Grizard
April 2003, European journal of applied physiology,
C Rochon, and I Tauveron, and C Dejax, and P Benoit, and P Capitan, and A Fabricio, and C Berry, and C Champredon, and P Thieblot, and J Grizard
July 1993, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
C Rochon, and I Tauveron, and C Dejax, and P Benoit, and P Capitan, and A Fabricio, and C Berry, and C Champredon, and P Thieblot, and J Grizard
October 1982, European journal of pediatrics,
C Rochon, and I Tauveron, and C Dejax, and P Benoit, and P Capitan, and A Fabricio, and C Berry, and C Champredon, and P Thieblot, and J Grizard
February 1980, Endocrinologia japonica,
C Rochon, and I Tauveron, and C Dejax, and P Benoit, and P Capitan, and A Fabricio, and C Berry, and C Champredon, and P Thieblot, and J Grizard
February 1968, Folia endocrinologica,
C Rochon, and I Tauveron, and C Dejax, and P Benoit, and P Capitan, and A Fabricio, and C Berry, and C Champredon, and P Thieblot, and J Grizard
January 1997, Hormone research,
C Rochon, and I Tauveron, and C Dejax, and P Benoit, and P Capitan, and A Fabricio, and C Berry, and C Champredon, and P Thieblot, and J Grizard
October 1978, Nihon rinsho. Japanese journal of clinical medicine,
C Rochon, and I Tauveron, and C Dejax, and P Benoit, and P Capitan, and A Fabricio, and C Berry, and C Champredon, and P Thieblot, and J Grizard
June 1983, L'union medicale du Canada,
Copied contents to your clipboard!